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バイアスを可視化する
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In systematic reviews, the evaluation of the risk of bias and indirectness on effect estimates is essential to as-
sess the certainty of the body of evidence. A program in the programming language R was developed to execute
a meta-analysis adjusting for the effects of biases after assessing bias magnitudes, directions, and uncertainty.
The program visualizes the effects of biases by creating an overlayered forest plot of bias-adjusted and
-unadjusted values. When performing meta-analyses and sensitivity analyses, this helps assess the certainty of
the body of evidence by setting various estimates for biases and indirectness of individual studies as risk ratios
and standard deviations or 95 % confidence intervals.
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Table　1　Data prepared on Excel for analysis
author nc rc nt rt label bias biasusd
Salminen P 2015 273 272 257 186 Author Year 1 1.1
Vons C 2011 119 104 120  72 Surgery 1 1.1
Hansson J 2009 167 142 202  83 Antibiotics 0.65 1
Styrud J 2006 124 124 128  97 Healing 0.8 0.95
Eriksson S 1995  20  20  20  13 Risk Ratio 0.8 0.95
RR
Author: Research ID; nc: total number of patients　in the control group; rc: number of 
risk events in the control group, nt: total number of patients in the treatment group; 
rt: number of risk (event) in the treatment group label: Research ID to be displayed in 
a forest plot; bias: the degree of indirectness and risk that is expressed as a risk ratio; 
biasusd: the value of＋1 standard deviation, the value of risk ratio before logarithmic 
transformation.
The value obtained by subtracting the logarithm of the bias value from that of the bi-
asusd value corresponds to one standard deviation of the normal distribution on a log-
arithmic scale. The value of -1 standard deviation is the exponential of the value ob-
tained by subtracting that value from the logarithm of the bias value, which is 
calculated from the values of bias and biasusd. Furthermore, the probability of falling 
within the range of±1 standard deviation is twice that of falling within any other 
range. On the other hand, when using the upper limit value of the 95% confidence in-
terval, the label used is biasuci. The pre-logarithmic-transformation value of the risk 
ratio is used in this case as well. Subtracting the logarithm of biasuci from the loga-
rithm of bias and dividing the resulting value by 1.96 yields a value equivalent to one 
standard deviation of the normal distribution on a logarithmic scale. The difference be-
tween the value of bias and the values of both biasusd and biasuci could be interpret-





















































































































































































































































































































































































































































































































































































































































Bias arising from randomization processす な わ ち
選択バイアスに含め，“Was the allocation sequence
random ?”，“Was the allocation sequence con-
cealed?”，“Were there baseline imbalances that sug-





Cochrane Handbook for Systematic Reviews of
Interventionsも現在の Version 5.1から 5.2へ改訂
作業中で一部は作業が終了しているようであるが，
大きな変更は行われないようである．現在のハンド
ブックの 8章 8.5.3 The judgementの項には以下の
42
―E42―
Fig.　1　Forest plots of meta-analysis based on the random-effects model





















Fig.　3　Forest plots of the meta-analysis before and after bias adjustment
























When only the effect on the uncertainty to the estimated value was assessed, without 
evaluating the direction and magnitude of the bias, we visualized the bias effect expressed 
by the risk ratio and the value of＋1 SD by using a forest plot.
Fig.　6　Forest plots of meta-analysis before and after bias adjustment
If the bias effect is perceived only as an effect on uncertainty, the value of the effective-
ness indicators of each study will not change, and the confidence interval will expand. The 
grey colour indicates having been bias-adjusted, and in this example, based on the use of 












Fig.　7　Results of the sensitivity analysis of the meta-analysis
Excluding Hansson J 2009, when only the effect on the uncertainty of each study was 
evaluated, the integrated value decreased from 0.730 (95 %CI 0.690-0.771) to 0.712 (0.621-
















て明確な判断をしない場合は，High risk of biasの判
定に対してバイアスの効果の標準偏差を大きく，
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